If you submitted a DEA registration application, something quiet has happened to your contract stack: it was all drafted for a business you no longer are. Nearly every cannabis agreement signed in California over the past decade rests on the shared assumption that cannabis is Schedule I and federally illegal. Your supply agreements, distribution contracts, leases, and licensing deals are full of language engineered around that fact.
The rescheduling order didn’t erase that assumption, but it split it. Medical marijuana under a state medical license now sits in Schedule III, and your medical-channel activity is federally recognized in a way your contracts likely never anticipated. Meanwhile, the adult-use market remains Schedule I, which means the old drafting is still accurate for some relationships and outdated for others. Contracts drafted around one legal reality are now operating in a different one, and it’s important to know where the mismatches are before a dispute, a diligence review, or an inspection finds them first.
However, balance still matters here. If a contract governs purely adult-use activity and its Schedule I assumptions remain accurate, and rewriting it may be a mistake. Channel-neutral boilerplate, confidentiality, indemnification frameworks, and most commercial terms don’t care what schedule the product is in. For a registrant with affiliated adult-use business, this isn’t a rip-up-everything moment; it’s a sorting exercise, and the sorting line runs between your channels.
What a registrant’s new agreements should Consider
Going forward, contracts involving your registered operations should be drafted for the business you are now, rather than patched from Schedule I templates. Here’s a non-exhaustive list of sections to consider revising:
- Registration reps and notices. Counterparty representations about DEA registration status, and an obligation to notify you promptly if that status is threatened or a state license issue could trigger suspension.
- Suspension triggers. What happens to the deal, to pending orders, and to product in transit if a party’s registration suspends mid-term? Silence on may be the biggest gap in the current generation of supply and distribution agreements.
- Channel designation. Which market the product is destined for, who bears the risk of misdesignation, and how the parties handle product that crosses channels. For a registrant, misdesignation isn’t just a state compliance issue anymore.
- Regulatory-change provisions. Federal guidance is still arriving. A reopener or renegotiation trigger keyed to material regulatory change beats renegotiating from scratch, or litigating, if the rules shift.
The practical move: triage, not panic. Inventory your active agreements, sort them by channel (medical, adult-use, mixed) and by importance (ongoing supply and distribution relationships, leases for registered premises, and licensing deals first), and flag the Schedule I-dependent provisions in each. Most registrants find three categories: contracts that are fine as-is, contracts worth amending at the next renewal, and a small set worth amending now because the counterparty relationship, the dollar value, or the registration risk justifies it.
Kocot Law reviews cannabis contracts on fixed fees with quoted turnaround: a portfolio triage that tells you which agreements fall in which category, and redlines or amendments for the ones that need them. Call or text (916) 572-6445 for a free 15-minute consult.
FAQ
I operate in both channels. Do all my contracts need updating?
Probably not. Contracts governing purely adult-use activity rest on premises that may still be accurate, since adult-use remains Schedule I. The review is a sorting exercise across your portfolio, not a wholesale rewrite.
What should a DEA registration applicant review first?
Ongoing supply and distribution agreements involving medical-channel products or DEA-registered counterparties, followed by leases for registered premises. These are where registration status, suspension risk, and channel designation may have the most practical consequences.
Should new contracts still include federal illegality language?
For adult-use transactions, some of it remains appropriate. For medical-channel transactions involving registrants, recitals and risk allocations should reflect Schedule III status, registration obligations, and the possibility of further regulatory change.
Attorney Advertising. This article is for general information only and is not legal advice; reading it or contacting Kocot Law does not create an attorney-client relationship. The effect of rescheduling on any particular agreement depends on its terms, the parties’ circumstances, and evolving federal guidance.
